Next generation tumor-targeting
Our proprietary Click Activated Protodrugs Against Cancer (CAPAC®) approach uses 2022 Nobel Prize-winning technology, click chemistry, to activate cancer therapies at the tumor.
We are the first company to use click chemistry inside human patients.